Search

everythinglearnresearchcommunity

for

Search:↓

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Mice without certain skin proteins had abnormal skin and hair development.

Adult skin cells can be used to create new hair in a lab.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.

New treatments targeting specific genes show promise for treating keratin disorders.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

Histone H4, released by cells exposed to colchicine, can cause hair loss by inhibiting cell growth and enzyme activity.

Hair follicle culture helps study hair growth but has limitations in modeling the full hair cycle.

Colchicine can inhibit hair growth by affecting cell activity and protein expression in hair follicles.

Researchers found a way to grow cashmere goat hair cells in a lab and discovered that certain conditions improve these cells' growth and characteristics.

New hair spray caused a hair shaft disorder.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Disrupting the FGF5 gene in rabbits leads to longer hair by extending the hair growth phase.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Collagen XVII is crucial for skin cell growth and nail health.

Hair follicle melanocytes die during hair regression.

P-cadherin is crucial for hair follicle pigmentation but not skin pigmentation.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.